2026 ASCP Research & Education Poster Session

Explore research and educational projects presented by colleagues at the 2026 ASCP Annual Meeting & Exhibition. The Poster Session offers an opportunity to discover new findings, discuss projects with authors, and connect with fellow attendees. Visit the posters during Friday’s Exhibit Hall Grand Opening & Poster Presentations or Saturday’s Exhibits & Coffee Break.
Friday, October 30 4:45–7:15 PM ET
Exhibit Hall Grand Opening & Poster Presentations
Saturday, October 31 11:15 AM–12:45 PM ET
Exhibits & Coffee Break
Exhibit Hall B/C Gaylord National

About the Poster Session

Poster presentations give authors an opportunity to share their work, contribute to the profession, and discuss their findings with attendees. Accepted abstracts in select categories will be published in the PubMed-indexed journal The Senior Care Pharmacist and on the ASCP Annual Meeting website. Learn more about the Poster Session and submission guidelines .

Browse the 2026 Research & Education Posters online by category.

Explore All Posters →

Poster Presentation Schedule

Find a presentation by day and station. Select a station to view its posters and presenters.

Friday, October 30

4:45–7:15 PM ET · Exhibit Hall B/C

Station 110 presentations
4:45–5:00 PM
Poster #2

Integrating Nonpharmacologic Intervention AlzhaTV With Pharmacist-Led Deprescribing in Skilled Nursing Facilities

Presenter: Smita U. Varshney

5:00–5:15 PM
Poster #5

Acetylcholinesterase Inhibitors and CMS Psychotropic Quality Measures in Long-Term Care: A Literature Review

Presenter: Casondra Seibert

5:15–5:30 PM
Poster #6

Evaluation of High-Risk Medication Use in Fall-Related Emergency Department Visits in Older Adults

Presenter: Savannah Cook

5:30–5:45 PM
Poster #7

Healthcare Students’ Confidence in Applying the 2023 American Geriatric Society Beers Criteria for Older Adults

Presenter: Laura Finn

5:45–6:00 PM
Poster #8

Evaluating the Efficacy of Combined Education and Technology-Enabled Intervention to Improve Medication Adherence in Older Adults

Presenter: Creaque Tyler

6:00–6:15 PM
Poster #9

Putting the 4Ms into practice: A Pharmacist-Led Initiative for Age-Friendly Medication Optimization in a Community Teaching Hospital

Presenter: Nilupar Rahman

6:15–6:30 PM
Poster #10

Assessing Direct Oral Anticoagulant Prescribing Appropriateness in Older Adults: A Retrospective Chart Review

Presenter: Mackenna Marvin

6:30–6:45 PM
Poster #11

Unintentional Errors and Intentional Misuse of Opiates Among Older Adults: A 2020-2025 Poison Center Retrospective Analysis

Presenter: Tessa Timmerman

6:45–7:00 PM
Poster #12

Characterizing Unintentional Medication Exposures Among Older Adults Reported to a Poison Control Center: A Retrospective Analysis (2021–2023)

Presenter: Nneoma Ugwuanyi

Station 28 presentations
Available throughout: 4:45–7:15 PM ETThese eight presentations do not have individually assigned time slots.
Poster #13

Gastrointestinal Tolerability of Benzgalantamine in Long-term Care Residents with Alzheimer Disease

Presenter: Carson Harrod

Poster #14

Real-World Effects of Benzgalantamine on Neuropsychiatric Symptoms in Long-Term Care Residents with Alzheimer’s Disease

Presenter: Pavel Svintozelskiy

Poster #15

Real-World Acetylcholinesterase Inhibitor Treatment Patterns and Transition to Benzgalantamine in Long-Term Care Residents with Alzheimer's Disease

Presenter: Kurt Grady

Poster #16

Real-World Effects of Benzgalantamine on Sleep-Related Outcomes in Long-Term Care Residents with Alzheimer's Disease

Presenter: Kurt Grady

Poster #17

Real-World Effects of Benzgalantamine on Psychotropic Medication Utilization in Long-term Care Residents with Alzheimer’s Disease

Presenter: Pavel Svintozelskiy

Poster #18

Effects of Benzgalantamine Use on Cognition in Long-term Care Residents with Alzheimer Disease

Presenter: Carson Harrod

Poster #19

Real-World Effects of Benzgalantamine on Activities of Daily Living in Long-Term Care Residents with Alzheimer's Disease

Presenter: Kurt Grady

Poster #20

Real-World Outcomes of Benzgalantamine Therapy in Long-Term Care Residents with Alzheimer's Disease Previously Treated with Donepezil: A Subgroup Analysis

Presenter: Pavel Svintozelskiy

Station 310 presentations
4:45–5:00 PM
Poster #25

Case Report of Early Onset Dementia with Possible link to Hormone Replacement Therapy

Presenter: Makenna Fox

5:00–5:15 PM
Poster #1

Evaluating the Economic Burden of Low Influenza Vaccination Rates in the U.S.: Implications for Occupational and Public Health

Presenter: Sabrina Martinez

5:15–5:30 PM
Poster #3

Protecting the Most Vulnerable: Pharmacist-Led Strategies for Sustainable LTC Immunization

Presenter: Jeanne Manzi

5:30–5:45 PM
Poster #27

Plastic Waste in Healthcare: Current Environmental Burden, Emerging Sustainable Packaging Alternatives, and Implications for Pharmacy Practice

Presenter: Camarlin Franco

5:45–6:00 PM
Poster #28

Narrative Review of Pharmacist-Led Deprescribing Interventions in People Living with Dementia

Presenter: Katherine Daugherty

6:00–6:15 PM
Poster #29

Validating an Evidence-Based Deprescribing Tool for Older Adults

Presenter: Puneet Bhutta

6:15–6:30 PM
Poster #30

A Decade of Clinical Pharmacist and Pharmacy Technician Role Innovation in the PACE Model of Care

Presenter: Janis Rood

6:30–6:45 PM
Poster #33

Evaluation of Clinical Outcomes Following Antipsychotic Gradual Dose Reduction Among Skilled Nursing Residents

Presenter: Nazek Salem

6:45–7:00 PM
Poster #34

Inclusion of Anticholinergic Risk Burden in Drug Regimen Reviews - A Quality Improvement Initiative

Presenter: Christine O'Neil

7:00–7:15 PM
Poster #54

Uncontrolled Hypertension in Older Adults: A Pharmacist-Led Community Screening Initiative in Under-Resourced Populations

Presenter: Darya Dodseresht

Station 47 presentations
4:45–5:00 PM
Poster #35

Evaluating Medicare Star Ratings Anticholinergic Polypharmacy Quality Measure Rates Among Medicare Beneficiaries ≥65 Years With and Without Tardive Dyskinesia

Presenter: Jillian Baer

5:00–5:15 PM
Poster #42

Real-World Dosing and Utilization of VMAT2 Inhibitors Among Patients with Tardive Dyskinesia Residing in Long-Term Care Settings

Presenter: Jillian Baer

5:15–5:30 PM
Poster #38

The Patient-Reported Tardive Dyskinesia Impact Scale (TDIS) in Patients ≥65 Years of Age Treated With Once-Daily Valbenazine: Findings From KINECT-PRO™

Presenter: Christine Holman

5:30–5:45 PM
Poster #44

Functional Improvements With Once-Daily Valbenazine in Patients With Tardive Dyskinesia in Long-Term Care

Presenter: Christine Holman

5:45–6:00 PM
Poster #39

A Modified Delphi Panel on the Screening, Diagnosis, and Treatment of Tardive Dyskinesia in Long-Term Care Settings

Presenter: Tariq Parwani

6:00–6:15 PM
Poster #45

Association between Valbenazine Initiation and Benztropine Discontinuation among Medicare Beneficiaries with Tardive Dyskinesia

Presenter: Jeff Herr

6:15–6:30 PM
Poster #43

Examining Dysphagia and Clinical Comorbidities at Diagnosis of Tardive Dyskinesia in Long-Term Care Settings

Presenter: Kaylee Mehlman

Station 59 presentations
4:45–5:00 PM
Poster #36

Low-Dose Vaginal Estrogen for Recurrent Urinary Tract Infection Prophylaxis in Postmenopausal Women: Comparison With Other Preventive Strategies

Presenter: Deborah Miller

5:00–5:15 PM
Poster #26

40 Years of ASCP's Peer Reviewed Journal

Presenter: Demetra Antimisiaris

5:15–5:30 PM
Poster #46

Applying the Medication Access Patient Journey (MAPJ) Framework to the Use of Lecanemab

Presenter: Samantha Paylor

5:30–5:45 PM
Poster #47

Trends in Antiseizure Medication Burden in U.S. Nursing Home Residents, 2010–2023

Presenter: Nicole Brandt

5:45–6:00 PM
Poster #48

Bridging Borders in Aging Care: A Collaborative Online International Learning (COIL) Model for Interprofessional Geriatric Education Between the United States and Finland

Presenter: Daniel Mansour

6:00–6:15 PM
Poster #49

Older Adult and Caregiver Perspectives on Age-Friendly Pharmacy Care

Presenter: Ashleigh Oliver

6:15–6:30 PM
Poster #50

Updates in Hospice Pharmacy Practice: A literature review

Presenter: Susan King

6:30–6:45 PM
Poster #52

Enhancing Dementia Care for Urban Indian Elders

Presenter: Morgan Masterson

6:45–7:00 PM
Poster #53

Assessment of the Opportunities and Barriers of Artificial intelligence throughout Pharmaceutical Practices: Perspectives from Healthcare Professionals in Arizona

Presenter: Sajad Al-zubaidy

Station 69 presentations
4:45–5:00 PM
Poster #4

Motor and Nonmotor Outcomes Among Patients With Parkinson’s Disease Psychosis Treated With Pimavanserin vs Other Atypical Antipsychotics in Long-Term Care Settings

Presenter: Nathan Crapo

5:00–5:15 PM
Poster #21

Real-World Comparative Analysis of Falls among Medicare Beneficiaries Newly Diagnosed with Parkinson’s Disease Psychosis initiating Pimavanserin versus Other Atypical Antipsychotics and Quetiapine

Presenter: Nathan Crapo

5:15–5:30 PM
Poster #22

Parkinson’s Disease Related Outcomes among Newly Diagnosed Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin versus Other Atypical Antipsychotics and Quetiapine

Presenter: Justin Machia

5:30–5:45 PM
Poster #32

Falls and Recurrent Falls Among Parkinson’s Disease Psychosis Patients Treated With Pimavanserin vs Other Atypical Antipsychotics in Long-Term Care/Nursing Home Settings

Presenter: Justin Machia

5:45–6:00 PM
Poster #24

Trends in Overactive Bladder Medication Administration Among US Nursing Home Residents

Presenter: Jeffrey Nesheim

6:00–6:15 PM
Poster #31

Real-World Treatment Patterns and Clinical Management of Alzheimer’s Disease Agitation

Presenter: Mike Donze

6:15–6:30 PM
Poster #41

Agitation in Alzheimer’s Disease: Association With Increased Clinical Burden, Healthcare Utilization, and Mortality Among Patients in Long-term Care

Presenter: Yang Zhao

6:30–6:45 PM
Poster #23

Incidence and Impact of Somnolence and Sedation With Brexpiprazole in Patients With Agitation Associated With Dementia Due to Alzheimer’s Disease

Presenter: Marco Ghiozzi

6:45–7:00 PM
Poster #40

Primary Care Perspectives on Sedation in the Management of Agitation in Alzheimer’s Dementia: Results from a Cross-Sectional Survey

Presenter: Marco Ghiozzi

Saturday, October 31

11:15 AM–12:45 PM ET · Exhibit Hall B/C

Station 110 presentations
11:15–11:24 AM
Poster #2

Integrating Nonpharmacologic Intervention AlzhaTV With Pharmacist-Led Deprescribing in Skilled Nursing Facilities

Presenter: Smita U. Varshney

11:24–11:33 AM
Poster #5

Acetylcholinesterase Inhibitors and CMS Psychotropic Quality Measures in Long-Term Care: A Literature Review

Presenter: Casondra Seibert

11:33–11:42 AM
Poster #6

Evaluation of High-Risk Medication Use in Fall-Related Emergency Department Visits in Older Adults

Presenter: Savannah Cook

11:42–11:51 AM
Poster #7

Healthcare Students’ Confidence in Applying the 2023 American Geriatric Society Beers Criteria for Older Adults

Presenter: Laura Finn

11:51 AM–12:00 PM
Poster #8

Evaluating the Efficacy of Combined Education and Technology-Enabled Intervention to Improve Medication Adherence in Older Adults

Presenter: Creaque Tyler

12:00–12:09 PM
Poster #9

Putting the 4Ms into practice: A Pharmacist-Led Initiative for Age-Friendly Medication Optimization in a Community Teaching Hospital

Presenter: Nilupar Rahman

12:09–12:18 PM
Poster #10

Assessing Direct Oral Anticoagulant Prescribing Appropriateness in Older Adults: A Retrospective Chart Review

Presenter: Mackenna Marvin

12:18–12:27 PM
Poster #11

Unintentional Errors and Intentional Misuse of Opiates Among Older Adults: A 2020-2025 Poison Center Retrospective Analysis

Presenter: Tessa Timmerman

12:27–12:36 PM
Poster #12

Characterizing Unintentional Medication Exposures Among Older Adults Reported to a Poison Control Center: A Retrospective Analysis (2021–2023)

Presenter: Nneoma Ugwuanyi

Station 28 presentations
Available throughout: 11:15 AM–12:45 PM ETThese eight presentations do not have individually assigned time slots.
Poster #13

Gastrointestinal Tolerability of Benzgalantamine in Long-term Care Residents with Alzheimer Disease

Presenter: Carson Harrod

Poster #14

Real-World Effects of Benzgalantamine on Neuropsychiatric Symptoms in Long-Term Care Residents with Alzheimer’s Disease

Presenter: Pavel Svintozelskiy

Poster #15

Real-World Acetylcholinesterase Inhibitor Treatment Patterns and Transition to Benzgalantamine in Long-Term Care Residents with Alzheimer's Disease

Presenter: Kurt Grady

Poster #16

Real-World Effects of Benzgalantamine on Sleep-Related Outcomes in Long-Term Care Residents with Alzheimer's Disease

Presenter: Kurt Grady

Poster #17

Real-World Effects of Benzgalantamine on Psychotropic Medication Utilization in Long-term Care Residents with Alzheimer’s Disease

Presenter: Pavel Svintozelskiy

Poster #18

Effects of Benzgalantamine Use on Cognition in Long-term Care Residents with Alzheimer Disease

Presenter: Carson Harrod

Poster #19

Real-World Effects of Benzgalantamine on Activities of Daily Living in Long-Term Care Residents with Alzheimer's Disease

Presenter: Kurt Grady

Poster #20

Real-World Outcomes of Benzgalantamine Therapy in Long-Term Care Residents with Alzheimer's Disease Previously Treated with Donepezil: A Subgroup Analysis

Presenter: Pavel Svintozelskiy

Station 310 presentations
11:15–11:24 AM
Poster #25

Case Report of Early Onset Dementia with Possible link to Hormone Replacement Therapy

Presenter: Makenna Fox

11:24–11:33 AM
Poster #1

Evaluating the Economic Burden of Low Influenza Vaccination Rates in the U.S.: Implications for Occupational and Public Health

Presenter: Sabrina Martinez

11:33–11:42 AM
Poster #54

Uncontrolled Hypertension in Older Adults: A Pharmacist-Led Community Screening Initiative in Under-Resourced Populations

Presenter: Darya Dodseresht

11:42–11:51 AM
Poster #3

Protecting the Most Vulnerable: Pharmacist-Led Strategies for Sustainable LTC Immunization

Presenter: Jeanne Manzi

11:51 AM–12:00 PM
Poster #27

Plastic Waste in Healthcare: Current Environmental Burden, Emerging Sustainable Packaging Alternatives, and Implications for Pharmacy Practice

Presenter: Camarlin Franco

12:00–12:09 PM
Poster #28

Narrative Review of Pharmacist-Led Deprescribing Interventions in People Living with Dementia

Presenter: Katherine Daugherty

12:09–12:18 PM
Poster #29

Validating an Evidence-Based Deprescribing Tool for Older Adults

Presenter: Puneet Bhutta

12:18–12:27 PM
Poster #30

A Decade of Clinical Pharmacist and Pharmacy Technician Role Innovation in the PACE Model of Care

Presenter: Janis Rood

12:27–12:36 PM
Poster #33

Evaluation of Clinical Outcomes Following Antipsychotic Gradual Dose Reduction Among Skilled Nursing Residents

Presenter: Nazek Salem

12:36–12:45 PM
Poster #34

Inclusion of Anticholinergic Risk Burden in Drug Regimen Reviews - A Quality Improvement Initiative

Presenter: Christine O'Neil

Station 47 presentations
11:15–11:24 AM
Poster #35

Evaluating Medicare Star Ratings Anticholinergic Polypharmacy Quality Measure Rates Among Medicare Beneficiaries ≥65 Years With and Without Tardive Dyskinesia

Presenter: Jillian Baer

11:24–11:33 AM
Poster #42

Real-World Dosing and Utilization of VMAT2 Inhibitors Among Patients with Tardive Dyskinesia Residing in Long-Term Care Settings

Presenter: Jillian Baer

11:33–11:42 AM
Poster #38

The Patient-Reported Tardive Dyskinesia Impact Scale (TDIS) in Patients ≥65 Years of Age Treated With Once-Daily Valbenazine: Findings From KINECT-PRO™

Presenter: Christine Holman

11:42–11:51 AM
Poster #44

Functional Improvements With Once-Daily Valbenazine in Patients With Tardive Dyskinesia in Long-Term Care

Presenter: Christine Holman

11:51 AM–12:00 PM
Poster #39

A Modified Delphi Panel on the Screening, Diagnosis, and Treatment of Tardive Dyskinesia in Long-Term Care Settings

Presenter: Tariq Parwani

12:00–12:09 PM
Poster #45

Association between Valbenazine Initiation and Benztropine Discontinuation among Medicare Beneficiaries with Tardive Dyskinesia

Presenter: Jeff Herr

12:09–12:18 PM
Poster #43

Examining Dysphagia and Clinical Comorbidities at Diagnosis of Tardive Dyskinesia in Long-Term Care Settings

Presenter: Kaylee Mehlman

Station 59 presentations
11:15–11:24 AM
Poster #36

Low-Dose Vaginal Estrogen for Recurrent Urinary Tract Infection Prophylaxis in Postmenopausal Women: Comparison With Other Preventive Strategies

Presenter: Deborah Miller

11:24–11:33 AM
Poster #26

40 Years of ASCP's Peer Reviewed Journal

Presenter: Demetra Antimisiaris

11:33–11:42 AM
Poster #46

Applying the Medication Access Patient Journey (MAPJ) Framework to the Use of Lecanemab

Presenter: Samantha Paylor

11:42–11:51 AM
Poster #47

Trends in Antiseizure Medication Burden in U.S. Nursing Home Residents, 2010–2023

Presenter: Nicole Brandt

11:51 AM–12:00 PM
Poster #48

Bridging Borders in Aging Care: A Collaborative Online International Learning (COIL) Model for Interprofessional Geriatric Education Between the United States and Finland

Presenter: Daniel Mansour

12:00–12:09 PM
Poster #49

Older Adult and Caregiver Perspectives on Age-Friendly Pharmacy Care

Presenter: Ashleigh Oliver

12:09–12:18 PM
Poster #50

Updates in Hospice Pharmacy Practice: A literature review

Presenter: Susan King

12:18–12:27 PM
Poster #52

Enhancing Dementia Care for Urban Indian Elders

Presenter: Morgan Masterson

12:27–12:36 PM
Poster #53

Assessment of the Opportunities and Barriers of Artificial intelligence throughout Pharmaceutical Practices: Perspectives from Healthcare Professionals in Arizona

Presenter: Sajad Al-zubaidy

Station 69 presentations
11:15–11:24 AM
Poster #4

Motor and Nonmotor Outcomes Among Patients With Parkinson’s Disease Psychosis Treated With Pimavanserin vs Other Atypical Antipsychotics in Long-Term Care Settings

Presenter: Nathan Crapo

11:24–11:33 AM
Poster #21

Real-World Comparative Analysis of Falls among Medicare Beneficiaries Newly Diagnosed with Parkinson’s Disease Psychosis initiating Pimavanserin versus Other Atypical Antipsychotics and Quetiapine

Presenter: Nathan Crapo

11:33–11:42 AM
Poster #22

Parkinson’s Disease Related Outcomes among Newly Diagnosed Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin versus Other Atypical Antipsychotics and Quetiapine

Presenter: Justin Machia

11:42–11:51 AM
Poster #32

Falls and Recurrent Falls Among Parkinson’s Disease Psychosis Patients Treated With Pimavanserin vs Other Atypical Antipsychotics in Long-Term Care/Nursing Home Settings

Presenter: Justin Machia

11:51 AM–12:00 PM
Poster #24

Trends in Overactive Bladder Medication Administration Among US Nursing Home Residents

Presenter: Jeffrey Nesheim

12:00–12:09 PM
Poster #31

Real-World Treatment Patterns and Clinical Management of Alzheimer’s Disease Agitation

Presenter: Mike Donze

12:09–12:18 PM
Poster #41

Agitation in Alzheimer’s Disease: Association With Increased Clinical Burden, Healthcare Utilization, and Mortality Among Patients in Long-term Care

Presenter: Yang Zhao

12:18–12:27 PM
Poster #23

Incidence and Impact of Somnolence and Sedation With Brexpiprazole in Patients With Agitation Associated With Dementia Due to Alzheimer’s Disease

Presenter: Marco Ghiozzi

12:27–12:36 PM
Poster #40

Primary Care Perspectives on Sedation in the Management of Agitation in Alzheimer’s Dementia: Results from a Cross-Sectional Survey

Presenter: Marco Ghiozzi

Times and presenters are subject to change.

Vote for Top Poster

Help select the 2026 Top Poster Award winner! Review the four nominated posters below. Voting is available to Annual Meeting attendees through the event app.

Voting closes Friday, October 30 at 9:00 PM ET.

The Top Poster Award winner will be announced during the Second General Session on Saturday, October 31, from 8:30–10:00 AM ET.

Top Poster Award Nominees

The following four posters have been nominated for the 2026 Top Poster Award. Review their titles and authors before casting your vote.

Poster #9

Putting the 4Ms Into Practice: A Pharmacist-Led Initiative for Age-Friendly Medication Optimization in a Community Teaching Hospital

Martin Sexton, PharmD, BCNSP; Maricelle Monteagudo-Chu, PharmD, BCPS, BCIDP; Shamsul Islam, PharmD, MBA; Nilupar Rahman, PharmD, BCPS

Poster #10

Assessing Direct Oral Anticoagulant Prescribing Appropriateness in Older Adults: A Retrospective Chart Review

Mackenna Marvin, PharmD Candidate; Erin Suhrie, PharmD, BCPS, BCGP; Nan Jones, RN; Karen Scandrett, MD; Christine M. Ruby, PharmD, BCPS, BCGP, FASCP

Poster #11

Unintentional Errors and Intentional Misuse of Opiates Among Older Adults: A 2020-2025 Poison Center Retrospective Analysis

Amanda Korenoski, PharmD, MHA, BCCCP; Christine M. Ruby, PharmD, BCPS, BCGP, FASCP; Tessa Timmerman, PharmD Candidate

Poster #48

Bridging Borders in Aging Care: A Collaborative Online International Learning (COIL) Model for Interprofessional Geriatric Education Between the United States and Finland

Daniel Z. Mansour, PharmD, MS, AGSF, BCGP, FASCP; Diane B. Martin, PhD, MSL, MA; Marja S. A. Airaksinen, PhD, MSc Pharm; Nicole J. Brandt, PharmD, MBA, BCGP, FASCP